1. Research advancements for early detection and/or monitoring of communicable diseases and substance abuse: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
2. Development of tools/tests for detection of Leptospirosis, rabies and soil-transmitted helminthiasis
3. Diagnostics for non-communicable diseases
PRIORITIES FOR 2023
1. Research advancements for early detection and/or monitoring of communicable diseases and substance abuse: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that detect and identify volatile organic compound biomarkers for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
b. Studies on the development of rapid, cost-effective, and minimally invasive diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
c. Studies that assess the effectiveness of remote diagnostics for respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
d. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
e. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
f. Studies on the detection of drug resistance to HIV g. Researches on HIV subtype
h. Researches related to the screening tests for the diagnosis of liver diseases i. Development of kits/tools for substance abuse
2. Development of tools/tests for detection of Leptospirosis, rabies and soil-transmitted helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Studies on CRISPR technology in controlling parasitic diseases responsible in various infections
d. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Studies on point-of-care assays of the early onset manifestation of cancer tumors
PRIORITIES FOR 2024
1. Research advancements for early detection and/or monitoring of communicable diseases: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that detect and identify volatile organic compound biomarkers for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
b. Studies on the development of rapid, cost-effective, and minimally invasive diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19 c. Studies that assess the effectiveness of remote diagnostics for respiratory diseases
such as influenza, pneumonia, tuberculosis, and COVID-19
d. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
e. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
f. Studies on the detection of drug resistance to HIV g. Researches on HIV subtype
h. Researches related to the screening tests for the diagnosis of liver diseases 2. Development of tools/tests for detection of Leptospirosis, rabies and soil-transmitted
helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Studies on CRISPR technology in controlling parasitic diseases responsible in various infections
d. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Studies on multi-epitope peptide vaccine against cancer
PRIORITIES FOR 2025
1. Research advancements for early detection and/or monitoring of communicable diseases: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that validate volatile organic compound biomarkers which can be used for developing devices for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
b. Studies on the development of rapid, cost-effective, and minimally invasive diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19 c. Studies that assess the effectiveness of remote diagnostics for respiratory diseases
such as influenza, pneumonia, tuberculosis, and COVID-19
d. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
e. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
f. Studies on the detection of drug resistance to HIV g. Researches on HIV subtype
h. Researches related to the screening tests for the diagnosis of liver diseases 2. Development of tools/tests for detection of Leptospirosis, rabies and soil-transmitted
helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Studies on CRISPR technology in controlling parasitic diseases responsible in various infections
d. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Researches on deoxyribonucleic acid (DNA) vaccine for cancer immunotherapy
PRIORITIES FOR 2026
1. Research advancements for early detection and/or monitoring of communicable diseases: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that utilize volatile organic compound biomarkers for diagnostic devices for early detection and monitoring of respiratory diseases
b. Studies that validate developed diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
c. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
d. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
e. Studies on the detection of drug resistance to HIV f. Researches on HIV subtype
g. Researches related to the screening tests for the diagnosis of liver diseases 2. Validation of tools/test for detection of Leptospirosis, rabies and soil-transmitted
helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Studies on CRISPR technology in controlling parasitic diseases responsible in various infections.
d. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Researches on the development of cancer diagnostic model dietary risk assessment through gut microbiome analysis
PRIORITIES FOR 2027
1. Research advancements for early detection and/or monitoring of communicable diseases: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that utilize volatile organic compound biomarkers for diagnostic devices for early detection and monitoring of respiratory diseases
b. Studies that conduct clinical testing on validated diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
c. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
d. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
e. Studies on the detection of drug resistance to HIV f. Researches on HIV subtype
g. Researches related to the screening tests for the diagnosis of liver diseases 2. Clinical testing of diagnostic tools for detection of Leptospirosis, rabies and soil-
transmitted helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Studies on CRISPR technology in controlling parasitic diseases responsible in various infections
d. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Studies on expression meta-analysis of predicted microRNA targets that identifies a diagnostic specified type of cancer
PRIORITIES FOR 2028
1. Research advancements for early detection and/or monitoring of communicable diseases: respiratory diseases, HIV, liver diseases, and other diseases associated with antimicrobial resistance
a. Studies that utilize volatile organic compound biomarkers for diagnostic devices for early detection and monitoring of respiratory diseases
b. Studies that commercialize clinically-tested diagnostic kits/devices/tools/tests for early detection and monitoring of respiratory diseases such as influenza, pneumonia, tuberculosis, and COVID-19
c. Studies on cell-mediated and humoral immunities to SARS-CoV-2 infection after vaccination
d. Studies on the development of multi-omics-based point-of-care detection tests for HIV and hepatitis
e. Studies on the detection of drug resistance to HIV f. Researches on HIV subtype
g. Researches related to the screening tests for the diagnosis of liver diseases 2. Commercialization of diagnostic tools/tests for detection of Leptospirosis, rabies and
soil-transmitted helminthiasis
a. Studies on the development of near-patient detection assay for leptospirosis b. Studies on point-of-care (POC) assays for detection of parasitic diseases through
ranges of clinical samples
c. Development of portable devices for efficient detection of bacterial and parasitic diseases
3. Diagnostics for non-communicable diseases
a. Studies on the development of multi-omics-based point-of-care detection tests for cancer and metabolic diseases
b. Researches on cancer molecular diagnostic kits
c. Studies on liquid biopsy of cancer: multimodal diagnostic tool in clinical oncology d. Researches on measurements of hemoglobin A1c prediction of early symptoms of
diabetes and stroke and heart disease
e. Studies on the development for early detection of cancer cells through DNA nanostructured biomarkers